Comprehensive Guide to Purchasing and Using Regorafenib (Belvango)

Regorafenib (also known as Regorafenib, trade name: Byvango), as a highly efficient multi-target tyrosine kinase inhibitor, plays a key role in anti-tumor treatment. To ensure that patients can use this drug safely and effectively, this article will provide a comprehensive guide to the purchase and use of regorafenib.

1. Buying Guide

1. Formal channels: It is recommended to purchase the original drug of regorafenib through hospital pharmacies, large chain pharmacies or formal Internet drug purchase platforms. For generic drugs, you can consult professional overseas medical institutions. The sources of medicines from these channels are reliable and the quality is guaranteed.

2. Doctor’s prescription: Regorafenib is a prescription drug, and a doctor’s prescription is required when purchasing it. Please be sure to follow your doctor's instructions to ensure the rationality and safety of your medication.

3. Price and version: The price of regorafenib varies depending on the version and purchase channel. Different versions such as the Bayer version in Germany, the NATCO version in India, and the ASEAN version in Laos have different prices, and patients can choose according to their own economic conditions.

2. User Guide

1. Usage and Dosage: Use regorafenib strictly in accordance with the prescription and instructions issued by your doctor. The recommended dose is usually 160mg (4 tablets), once a day, taken orally in the first 21 days of each course of treatment, and 28 days constitute a course of treatment. The tablets should be swallowed whole with water at the same time every day, after a low-fat breakfast.

2. Adverse reaction monitoring: Pay close attention to adverse reactions during use, such as hand and foot skin reactions, fatigue, diarrhea, hypertension, etc. In the event of serious or persistent adverse reactions, you should seek medical treatment promptly and inform your doctor.

3. Dose adjustment: Based on safety and tolerability considerations, doctors may adjust the dose of regorafenib according to the patient’s specific conditions. Patients should follow the doctor's instructions, take the medicine on time and in the right amount, and are not allowed to increase or decrease the dose or stop the medicine on their own.

4. Note for special groups: Pregnant women, lactating women, children, and patients with severe liver and kidney dysfunction should avoid using regorafenib or use it with caution. Elderly patients also need to pay special attention to the occurrence of adverse reactions during use.

5. Drug interactions: Regorafenib may interact with certain drugs, affecting drug efficacy or increasing the risk of adverse reactions. Be sure to tell your doctor if you need to take other medicines while taking regorafenib.

In short, as an important anti-tumor drug, regorafenib must be purchased and used in strict compliance with medical instructions and instructions. We hope that this comprehensive guide will help patients better understand and use regorafenib and achieve safe and effective anti-tumor treatment.